Oxford Cannabinoid Technologies Holdings Plc Stock
Equities
OCTP
GB00BMVMRB86
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.12 GBX | -11.11% | -41.46% | -80.80% |
May. 31 | Oxford Cannabinoid Technologies Drops Matched Bargain Facility Plans Ahead of Delisting | MT |
May. 17 | Oxford Cannabinoid says it remains bound by Takeover Code | AN |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.47M 1.88M |
---|---|---|---|---|---|
Net income 2024 * | -2M -2.56M | Net income 2025 * | -3M -3.83M | EV / Sales 2024 * | - |
Net cash position 2024 * | 1.18M 1.51M | Net Debt 2025 * | 2.03M 2.59M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.61
x | P/E ratio 2025 * |
-0.47
x | Employees | 7 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 70.17% |
1 day | -11.11% | ||
1 week | -41.46% | ||
Current month | -11.11% | ||
1 month | -65.22% | ||
3 months | -72.73% | ||
6 months | -83.45% | ||
Current year | -80.80% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 44 | - | |
Paul Smalley
DFI | Director of Finance/CFO | - | 22-10-16 |
Chief Tech/Sci/R&D Officer | 55 | 20-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | - | |
Julie Pomeroy
CHM | Chairman | 69 | - |
Timothy Corn
CTO | Chief Tech/Sci/R&D Officer | 73 | 23-06-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 0.12 | -11.11% | 22 188 028 |
24-05-31 | 0.135 | -20.59% | 10,673,270 |
24-05-30 | 0.17 | -17.07% | 11,344,660 |
24-05-29 | 0.205 | 0.00% | 20,494,130 |
24-05-28 | 0.205 | 0.00% | 10,428,650 |
Delayed Quote London S.E., June 03, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-80.80% | 1.87M | |
+46.16% | 54.63B | |
-6.98% | 39.92B | |
+37.07% | 38.82B | |
+13.17% | 26.86B | |
-11.17% | 26.22B | |
-21.72% | 18.78B | |
+24.87% | 12.21B | |
+0.51% | 12.16B | |
+25.14% | 11.94B |
- Stock Market
- Equities
- OCTP Stock